Tampa, FL – January 26, 2006 – Pilgrim Software, Inc., the leading provider of Enterprise Quality and Compliance Management Solutions, announces that Celgene has gone live with SmartAudit to enhance and facilitate management of its auditing processes. Pilgrim’s off-the-shelf and comprehensive validation scripts expedited the validation process of SmartAudit which was completed in just over one month. Implementing SmartAudit is the first phase in the process of deploying Pilgrim’s SmartSolve suite at Celgene.

With Pilgrim’s SmartAudit implemented, Celgene has a scalable, off-the-shelf and validated system that allows them to eliminate paper-based processes. SmartAudit facilitates the creation, scheduling and execution of internal and external audits that Celgene is subjected to such as GLP, GCP and GMP.  SmartAudit enables Celgene to reduce audit cycle time, improve process efficiency and improve quality of audit data. Furthermore, Celgene reduced its costs by decreasing the amount of manual labor necessary to perform audits. 

“After evaluating many options, Celgene selected Pilgrim’s SmartSolve because it is an integrated solution that streamlines and automates existing processes,” said Prashanth Rajendran, Pilgrim Software’s Chief Operating Officer. “Celgene chose to deploy SmartAudit first because the solution provides key visibility into the state of regulatory compliance and operational control. SmartAudit ensured all audits are scheduled, executed and tracked.  In addition its electronic workflows ensure that findings, observations and action plans are reviewed and approved quickly by providing responsible parties with fast access to pending tasks and new information. The next phase of implementing SmartSolve is the deployment of SmartCAPA.”

About Celgene
Celgene Corporation, headquartered in Warren, NJ, is an integrated biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and debilitating inflammatory diseases through gene and protein regulation. They are current engaged in over 200 ongoing clinical trials at major medical centers worldwide, using innovative compounds from Celgene, with the outcome to be promising, new drugs that include many high-potential compounds in their rich regulatory pipeline. These investigational compounds may address immediate medical needs of patients with incurable hematological and solid tumor cancers. For more information, please visit Celgene’s website at www.celgene.com.

About Pilgrim Software, Inc.
Pilgrim Software, Inc. is the leading provider of Enterprise Compliance and Quality Management solutions for global organizations. Pilgrim helps organizations manage industry and regulatory compliance, reduce manufacturing costs, improve customer satisfaction and productivity. For more information, visit Pilgrim Software’s Web site at www.pilgrimsoftware.com.